Concepedia

Iris van Moort

IV

6

Publications

133

Citations

6

H-Index

2015

Active since

Affiliations

Radboud University Nijmegen(Current)

Erasmus MC

Erasmus MC - Sophia Children’s Hospital

Leiden University Medical Center

University Medical Center Groningen

Iris van Moort is an author at Radboud University Nijmegen specializing in hematology, pharmacotherapy, and thrombosis.

ORCID

Top concepts

Publications per year

2015–2021

6

Publications

6

Analysis of current perioperative management with Haemate<sup>®</sup> P/Humate P<sup>®</sup> in von Willebrand disease: Identifying the need for personalized treatment

H.C.A.M. Hazendonk, Jessica M. Heijdra, Nico C. B. de Jager et al. · Haemophilia · 2018 · 38 citations · Full text

Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme

Iris van Moort, Piet Meijer, Debby Priem‐Visser et al. · Haemophilia · 2018 · 26 citations · Full text

The “OPTI-CLOT” trial

H.C.A.M. Hazendonk, Iris van Moort, Karin Fijnvandraat et al. · Thrombosis and Haemostasis · 2015 · 22 citations

Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII

Tim Preijers, Iris van Moort, Karin Fijnvandraat et al. · Thrombosis and Haemostasis · 2018 · 22 citations

Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial

Iris van Moort, Tim Preijers, Laura H. Bukkems et al. · The Lancet Haematology · 2021 · 13 citations · Full text

, , +6

Rows per page

1–5 of 6